Target intelligence / Profile preview

Adhesion G protein-coupled receptor F1 (ADGRF1)

Target
ADGRF1
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor, Seven-transmembrane helix receptor
01

Overview

Adhesion G protein-coupled receptor F1 (ADGRF1), also known as G protein-coupled receptor 110 (GPR110), is a member of the adhesion class of GPCRs involved in diverse physiological processes, including immune responses, organ development, and maintenance of cellular homeostasis. It possesses a characteristic seven-transmembrane domain structure and undergoes autoproteolytic cleavage, after which its stalk region acts as a tethered agonist to activate the receptor. ADGRF1 couples to multiple G protein classes (Gs, Gi, and Gq), facilitating pleiotropic signaling. The receptor is functionally important in neural stem cells and has been recognized as an oncogene in several cancer types. It is directly activated by synaptamide, an endogenous lipid ligand that binds to a specific site on the intracellular region of the receptor. The detailed structural mechanism of activation demonstrates unique features compared to other GPCRs, particularly among the adhesion GPCR subclass[1][3].

Other names
GPR110PGR19G protein-coupled receptor 110hGPCR36KPG_012G protein-coupled receptor KPG_012Probable G protein-coupled receptor 110ADGRF1 N-terminal fragmentADGRF1 C-terminal fragment
02

Mechanism of action

Tethered agonist activation via the receptor’s own stalk region[1] Ligand-dependent activation by synaptamide (lipid-derived endogenous agonist)[1]

03

Biological functions

Signal transductionCellular communicationCell proliferationImmune responseOrgan developmentHomeostasis
04

Disease associations

Cancer (recognized as an oncogene in various cancers)Other (role in organ development and neurobiology suggested, but not definitively linked to other discrete disease classes at this time)
05

Interacting drugs

Synaptamide (N-docosahexaenoylethanolamine, endogenous ligand shown to activate ADGRF1)

Beyond the preview

Go deeper on Adhesion G protein-coupled receptor F1 (ADGRF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adhesion G protein-coupled receptor F1 (ADGRF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call